- World Health Organization dismisses Serum Institute of India petition
- The Serum Institute appealed to extend the shelf life of the Kovishield vaccine.
- WHO has cited insufficient data, will talk about India’s drug control
World Health Organization Made by Serum Institute of India Covshield vaccine Petition to extend shelf life of Rs. The WHO has stated that the data given for it is not sufficient. The Serum Institute appealed to WHO a few days ago to increase the shelf life of its vaccine from 6 months to 9 months.
What is Shelf Life
The shelf-life of any vaccine from manufacturing to the end of its use is called shelf life. In general terms, it is associated with the expiry date of the vaccine. Use of the vaccine is prohibited after this period. The WHO has also called for a meeting with the Drugs Controller General of India (DCGI) to discuss the matter.
India has already approved to extend the shelf life
The Drug Controller General of India has already extended the shelf life of Kovishield from six to nine months from its manufacturing date. In February, in a letter to the Pune-based Serum Institute of India, DCGI stated that it had no objection to the extension of the shelf life of the Kovishield vaccine up to 9 MB. This shelf life will apply to the multi-dose glass vial (10 doses – 5 ml) of the vaccine.
AstraZeneca vaccine has a shelf life of 6 months in the UK
Dr. VG Somani of the Drugs Controller General of India had said in the letter that you have the right to extend the shelf life of the unlabeled vaccine and the available stock yet to 9 months. The DCGI decision is expected to help save the vaccine that is deteriorating in hospitals. On 22 February, the UK drug regulator also reported the shelf life of AstraZeneca’s vaccine to be 6 months.